{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:17:43Z","timestamp":1784269063496,"version":"3.55.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Anal squamous cell carcinoma has rarely been reported in the setting of ulcerative colitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>This study aimed to understand the prognosis of anal squamous cell carcinoma in the setting of ulcerative colitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>This is a retrospective review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>This study was conducted at a referral center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Adult patients with both ulcerative colitis (556.9\/K51.9) and anal squamous cell carcinoma (154.3\/C44.520) between January 1, 2000 and August 1, 2019 were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOMES MEASURES:<\/jats:title>\n            <jats:p>The primary outcomes measured are treatment and survival of anal squamous cell carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of the 13,499 patients with ulcerative colitis treated, 17 adult patients with ulcerative colitis and anal dysplasia and\/or anal squamous cell carcinoma were included in the study: 6 had a diagnosis of anal squamous cell carcinoma, 8 had high-grade squamous intraepithelial lesions, and 3 had low-grade squamous intraepithelial lesions. There were 4 men (23%) and a median age of 55 years (range, 32\u201369) years. At diagnosis, 6 had an IPAA, of which 5 had active pouchitis, 1 had an ileorectal anastomosis with active proctitis, 1 had a Hartmann stump with disuse proctitis, 5 had pancolitis, and 4 had left-sided colitis. Of the 6 with anal squamous cell carcinoma, all received 5-fluorouracil and mitomycin C with external beam radiation therapy. Four patients had an IPAA, all of whom required intestinal diversion or pouch excision because of treatment intolerance. At a median follow-up of 60 months, 3 patients died: one at 0 months (treatment-related myocardial infarction), one at 60 months (metastatic anal squamous cell carcinoma), and one at 129 months (malignant peripheral nerve sheath tumor); the remaining patients had no residual disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATIONS:<\/jats:title>\n            <jats:p>This study was limited because of its retrospective nature and small number of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Anal squamous cell carcinoma in the setting of ulcerative colitis is extremely rare. In the setting of IPAA, diversion may be necessary to prevent radiation intolerance. Careful examination of the perianal region should be performed at the time of surveillance endoscopy. See <jats:bold>Video Abstract<\/jats:bold> at http:\/\/links.lww.com\/DCR\/B582.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CARCINOMA ANAL DE C\u00c9LULAS ESCAMOSAS EN COLITIS ULCEROSA: \u00bfPUEDE EL POUCH MODIFICAR LOS RESULTADOS DE LOS PROTOCOLOS DE TRATAMIENTO TRADICIONAL<\/jats:title>\n            <jats:p>\n                                 <jats:bold>ANTECEDENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>La incidencia de c\u00e1ncer anal de c\u00e9lulas escamosas es muy baja en pacientes con colitis ulcerosa.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>OBJETIVO:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Comprender el pron\u00f3stico del c\u00e1ncer anal de c\u00e9lulas escamosas en el contexto de la colitis ulcerosa.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>DISE\u00d1O:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Revisi\u00f3n retrospectiva.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>AJUSTE:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Centro de referencia.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>PACIENTES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Pacientes adultos con colitis ulcerosa (556.9 \/ K51.9) y c\u00e1ncer anal de c\u00e9lulas escamosas (154.3 \/ C44.520) entre el 1 de enero de 2000 y el 1 de agosto de 2019.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>RESULTADOS PRINCIPALES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Tratamiento y sobrevida del c\u00e1ncer anal de c\u00e9lulas escamosas.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>RESULTADOS:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>De 13.499 pacientes en tratamiento por colitis ulcerosa, diecisiete presentaron displasia y\/o c\u00e1ncer de c\u00e9lulas escamosas: 6 con c\u00e1ncer, 8 con lesiones intraepiteliales escamosas con displasia de alto grado y 3 con displasia de bajo grado.<\/jats:p>\n            <jats:p>Cuatro son hombres (23 %) con una mediana de 55 a\u00f1os (rango 32-69). Al realizar el diagn\u00f3stico 6 ten\u00edan pouch, 5 con pouchitis activa; 1 con ileorecto anastomosis con proctitis activa y 1 con operaci\u00f3n de Hartman y mu\u00f1\u00f3n con colitis por desuso; adem\u00e1s 5 ten\u00edan pancolitis y 4 ten\u00edan colitis izquierda<\/jats:p>\n            <jats:p>Todos los casos con c\u00e1ncer anal de c\u00e9lulas escamosas (6 pacientes), fueron tratados con 5-FU mas Mitomicina y radioterapia externa. Cuatro pacientes ten\u00edan pouch, todos requirieron derivaci\u00f3n intestinal o escisi\u00f3n del pouch por intolerancia al tratamiento.<\/jats:p>\n            <jats:p>En la mediana de seguimiento de 60 meses, tres pacientes fallecieron: uno a los 0 meses (infarto de miocardio relacionado con el tratamiento), uno a los 60 meses (c\u00e1ncer de c\u00e9lulas escamosas metast\u00e1sico) y uno a los 129 meses (tumor maligno de la vaina del nervio perif\u00e9rico); el resto no presentaba enfermedad residual.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>LIMITACIONES:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>Revisi\u00f3n retrospectiva, n\u00famero peque\u00f1o de pacientes.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>CONCLUSI\u00d3N:<\/jats:bold>\n                              <\/jats:p>\n            <jats:p>El c\u00e1ncer anal de c\u00e9lulas escamosas en el contexto de la colitis ulcerosa es extremadamente raro. En el contexto de IPAA, la derivaci\u00f3n puede ser necesaria para prevenir la intolerancia a la radiaci\u00f3n. Se debe realizar un examen cuidadoso de la regi\u00f3n perianal en el momento de la endoscopia de control. Consulte <jats:bold>Video Resumen<\/jats:bold> en http:\/\/links.lww.com\/DCR\/B582.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dcr.0000000000002011","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T08:27:30Z","timestamp":1620376050000},"page":"1106-1111","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?"],"prefix":"10.1097","volume":"64","author":[{"given":"Amy L.","family":"Lightner","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashansha","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McMichael","sequence":"additional","affiliation":[{"name":"General Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Click","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Steele","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Hull","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European evidence-based consensus: inflammatory bowel disease and malignancies.","volume":"9","author":"Annese","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1054\/bjoc.2000.1153","article-title":"Anal carcinoma in inflammatory bowel disease.","volume":"83","author":"Frisch","year":"2000","journal-title":"Br J Cancer"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.suronc.2013.08.002","article-title":"A systematic review of anal squamous cell carcinoma in inflammatory bowel disease.","volume":"22","author":"Slesser","year":"2013","journal-title":"Surg Oncol"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019.","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002030-199403000-00001","article-title":"Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem.","volume":"8","author":"Palefsky","year":"1994","journal-title":"AIDS"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00384-017-2794-8","article-title":"Long-standing Crohn\u2019s disease and its implication on anal squamous cell cancer management.","volume":"32","author":"Lightner","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/ctg.2016.8","article-title":"Anal neoplasia in inflammatory bowel disease is associated with hpv and perianal disease.","volume":"7","author":"Ruel","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/SLA.0b013e31827d99a2","article-title":"Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.","volume":"257","author":"Fazio","year":"2013","journal-title":"Ann Surg"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jamcollsurg.2013.11.019","article-title":"Functional outcomes and complications after restorative proctocolectomy and ileal pouch anal anastomosis in the pediatric population.","volume":"218","author":"Ozdemir","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02604287","article-title":"Combined therapy for cancer of the anal canal.","volume":"24","author":"Nigro","year":"1981","journal-title":"Dis Colon Rectum"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10350-007-9125-z","article-title":"Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.","volume":"51","author":"Roohipour","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/j.prro.2015.03.002","article-title":"Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis.","volume":"5","author":"Cherian","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/codi.14467","article-title":"Does external beam radiation therapy to the pelvis portend worse ileal pouch outcomes? An international multi-institution collaborative study.","volume":"21","author":"Lightner","year":"2019","journal-title":"Colorectal Dis"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.urology.2008.06.052","article-title":"Prostate brachytherapy after ileal pouch-anal anastomosis reconstruction.","volume":"73","author":"Williamson","year":"2009","journal-title":"Urology"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/j.crohns.2013.01.017","article-title":"Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer.","volume":"7","author":"Wu","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025.","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ibd.20029","article-title":"Update on the incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.","volume":"13","author":"Loftus","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4137\/CMO.S13241","article-title":"Human papilloma virus and squamous cell carcinoma of the anus.","volume":"8","author":"Gami","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ijc.25080","article-title":"Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005.","volume":"127","author":"Sunesen","year":"2010","journal-title":"Int J Cancer"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.gie.2015.01.053","article-title":"Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer.","volume":"82","author":"Shergill","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"suppl 1","key":"R22-20250505","doi-asserted-by":"crossref","first-page":"S-410","DOI":"10.1016\/S0016-5085(13)61510-3","article-title":"Inflammatory bowel disease patients have a high prevalence of anal human papillomavirus and anal dysplasia.","volume":"144","author":"Cranston","year":"2013","journal-title":"Gastroenterology"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.cgh.2015.05.031","article-title":"Prevalence of anal dysplasia in patients with inflammatory bowel disease.","volume":"13","author":"Shah","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/000313481307901023","article-title":"Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.","volume":"79","author":"Metildi","year":"2013","journal-title":"Am Surg"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:28:35Z","timestamp":1746487715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000002011","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,26]]}}}